Y-mAbs Therapeutics, Inc. Shareholder Alert: Kaplan Fox Investigates Potential Securities Fraud
04. November 2022 09:00 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Y-mAbs Therapeutics, Inc. (“Y-mAbs” or the...